148 related articles for article (PubMed ID: 4198846)
1. [Determination of fibrinogen and fibrin degradation products (DFP) in the acute stage of myocardial infarction].
Baele G; Mussche M; Vermeire P; Pannier R
Arch Mal Coeur Vaiss; 1973 Apr; 66(4):427-9. PubMed ID: 4198846
[No Abstract] [Full Text] [Related]
2. [Circulating levels of products of fibrinogen and fibrin monomer degradation in liver cirrhosis].
Rocha E; López Borrasca A
Rev Med Univ Navarra; 1974; 18(3-4):143-7. PubMed ID: 4471076
[No Abstract] [Full Text] [Related]
3. A study of soluble fibrin monomer complexes (SFMC) and plasma fibrinogen in acute myocardial infarction.
Jain SM; Trivedi S
Indian J Chest Dis Allied Sci; 1984; 26(2):98-103. PubMed ID: 6530267
[No Abstract] [Full Text] [Related]
4. [Fibrinogen and fibrin degradation products in the blood of acute myocardial infarct patients at the hospital rehabilitation stage].
Solov'ev AV; Ermolin GA; Ignashenkova GV; Dikov MM
Ter Arkh; 1987; 59(10):21-3. PubMed ID: 3324376
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
Heene DL; Genth K
Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
[No Abstract] [Full Text] [Related]
6. Degradation products of fibrinogen and crosslinked fibrin-projected clinical applications.
Marder VJ; Budzynski AZ
Thromb Diath Haemorrh; 1974 Sep; 32(1):49-56. PubMed ID: 4616425
[No Abstract] [Full Text] [Related]
7. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
8. [Hypofibrinolysis and thrombophilia].
Cepelák V; Dvorák J; Cepeláková H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):456-67. PubMed ID: 6083911
[TBL] [Abstract][Full Text] [Related]
9. Detection of hypercoagulable states with protamine sulphate tests.
Lipinski B
Acta Univ Carol Med Monogr; 1972; 52():185-8. PubMed ID: 4273929
[No Abstract] [Full Text] [Related]
10. Comparison of ethanol and protamine tests in demonstration of soluble fibrin and early products of fibrin degradation.
Konttinen YP; Kemppainen L; Turunen O
Thromb Diath Haemorrh; 1972 Dec; 28(3):342-50. PubMed ID: 4675265
[No Abstract] [Full Text] [Related]
11. Value of determination of serum fibrin-fibrinogen degradation products in acute myocardial infarction.
Okuno T; Nelson C
Am J Clin Pathol; 1974 Feb; 61(2):155-9. PubMed ID: 4811734
[No Abstract] [Full Text] [Related]
12. [The detection of preventive hypofibronectinemia in diagnosing the development of disseminated intravascular coagulation in patients with myocardial infarction at the hospital rehabilitation stage].
Solov'ev AV; Ermolin GA; Soroka VR
Ter Arkh; 1993; 65(9):22-4. PubMed ID: 8303587
[TBL] [Abstract][Full Text] [Related]
13. [Fibrinogen and fibrin degradation products in serum and their prognostic significance in acute myocardial infarct].
Krug H; Gryglik J; Jasiński K; Gluszek J
Kardiol Pol; 1977; 20(1):9-14. PubMed ID: 846061
[No Abstract] [Full Text] [Related]
14. [Fibrinogen-fibrin degradation products (FDP) in patients with various diseases].
Matsuda T
Nihon Ketsueki Gakkai Zasshi; 1972 Oct; 35(5):628-36. PubMed ID: 4677378
[No Abstract] [Full Text] [Related]
15. Serum fibrin-fibrinogen degradation products in acute myocardial infarction.
Baele G; Mussche M; Vermeire P
Lancet; 1972 Mar; 1(7752):689-90. PubMed ID: 4125193
[No Abstract] [Full Text] [Related]
16. [The behaviour of fibrinogen and fibrinogen degradation products in myocardial infarction. Justification of a prognostic index (author's transl)].
Abizanda Campos R; Forner Sánchez N; Carrió Soldevilla M; Florit Serra J
Med Clin (Barc); 1979 Dec; 73(10):429-34. PubMed ID: 529865
[TBL] [Abstract][Full Text] [Related]
17. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
Colick JA; Fisher LM
Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
[No Abstract] [Full Text] [Related]
18. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
Lychev VG; Momot AP; Cherkashin GV
Ter Arkh; 1984; 56(6):106-9. PubMed ID: 6474366
[TBL] [Abstract][Full Text] [Related]
19. [Intravascular thrombus formation and problems of laboratory control in coronary insufficiency].
Lyusow WA; Belousow JB; Parfjenow AS; Sawenkow MP; Pantschenko EP
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):176-9. PubMed ID: 6177601
[No Abstract] [Full Text] [Related]
20. Clinical significance of cross-linked fibrin degradation products in essential mixed cryoglobulinemia.
Fiorini G; Toschi V; Motta A; Gagliano MG; Gibelli A
Biomed Pharmacother; 1988; 42(9):605-7. PubMed ID: 3240365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
